enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. A Full List of Recalled Eye Drops Linked to Potential ... - AOL

   www.aol.com/full-list-recalled-eye-drops...

   EzriCare Artificial Tears Lubricant Eye Drops: According to the CDC, this product was implicated as a common factor in 37 of the 68 logged cases so far. Potentially tainted eye drops can be ...

3. Over 27 Eye Drops Have Been Recalled: What You Need to Know - AOL

   www.aol.com/lifestyle/eye-drop-recall-know...

   Find a list of recalled drops in 2023. Plus, eye infection symptoms. Eye drops are being recalled due to a rare bacterium found in artificial tears. Find a list of recalled drops in 2023.

4. Alcon - Wikipedia

   en.wikipedia.org/wiki/Alcon

   Alcon offices in Johns Creek, Georgia. Alcon Inc. ( German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. [2]

5. FDA issues voluntary recall of certain eye drop brands sold ...

   www.aol.com/fda-warns-certain-eye-drop-153352566...

   “Under the Federal Food, Drug and Cosmetic Act, eye drops must be sterile to be safe for use,” it added. Dr Berne’s MSM Drops 5 per cent Solution has a bacterial contamination known as ...

6. Olopatadine - Wikipedia

   en.wikipedia.org/wiki/Olopatadine

   Olopatadine. Olopatadine, sold under the brand name Patanol among others, is an antihistamine medication used to decrease the symptoms of allergic conjunctivitis and allergic rhinitis (hay fever). [ 2] It is used as eye drops or as a nasal spray. [ 2] The eye drops generally result in an improvement within half an hour.

7. 2022–2023 United States P. aeruginosa outbreak in eye drops

   en.wikipedia.org/wiki/2022–2023_United_States_P...

   outbreak in eye drops. The 2022–2023 United States Pseudomonas aeruginosa outbreak began in May 2022, with the infection of several patients in California. The Centers for Disease Control and Prevention (CDC) became aware of a strain of Pseudomonas aeruginosa in artificial tears manufactured by EzriCare and Delsam Pharma in January 2023.